4//SEC Filing
HAYWARD SURRY JEREMY 4
Accession 0001245362-05-000001
CIK 0000722104other
Filed
Jan 3, 7:00 PM ET
Accepted
Jan 4, 3:29 PM ET
Size
11.2 KB
Accession
0001245362-05-000001
Insider Transaction Report
Form 4
HAYWARD SURRY JEREMY
Director
Transactions
- Award
Options to purchase common stock, $.01 par value per share
2004-12-31$2.71/sh+10,000$27,100→ 40,833 totalExercise: $2.71From: 2005-12-31Exp: 2014-12-31→ Common stock, $.01 par value per share (10,000 underlying) - Award
Common stock, $.01 par value per share
2004-12-31$2.71/sh+2,310$6,260→ 6,637 total
Footnotes (2)
- [F1]These shares were granted pursuant to the Company's 2004 Incentive Plan, which provides for the grant to non-employee directors of that number of shares of Common Stock having an aggregate fair market value on the last business day of each quarter equal to $3,750.00, until he is no longer an Outside Director. The non-executive Chairperson is granted that number of shares of Common Stock having an aggregate fair market value on the last business day of each quarter equal to $8,000.00. Mr. Hayward-Surry was elected non-executive Chairperson of the Board on October 21, 2004 and his stock grant was accordingly prorated to such date. On December 31, 2004, the fair market value of the Common Stock, based on the closing price, was $2.71.
- [F2]The non-executive Chairperson receives grants of 10,000 options to purchase Common Stock, $.01 par value per share, on the last day of each quarter. These options will become fully vested and immediately exercisable on 12/31/2005.
Documents
Issuer
SAVIENT PHARMACEUTICALS INC
CIK 0000722104
Entity typeother
Related Parties
1- filerCIK 0001245362
Filing Metadata
- Form type
- 4
- Filed
- Jan 3, 7:00 PM ET
- Accepted
- Jan 4, 3:29 PM ET
- Size
- 11.2 KB